Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on June 11, 2025
CLSI partners with LymeX Diagnostics Prize to support Phase 4 team advancing Lyme disease diagnostics
GlobeNewswire
·
June 11, 2025
MALVERN, Pa., June 11, 2025 (GLOBE NEWSWIRE) -- Clinical …
Gapin Institute and Bauman Medical Announce Strategic Partnership – “Peak Launch: Personalized Longevity and Hair Optimization—powered by Gapin Institute for Bauman Medical”
GlobeNewswire
·
June 11, 2025
BOCA RATON, Fla. and SARASOTA, Fla., June 11, 2025 (GLOBE NEWSWIRE) -- The Gapin Institute for Precision Medicine, a global leader in longevity, and Bauman Medical, a global leader in hair restoration and scalp health, are proud to announce the launch of a …
Cabaletta Bio Announces Pricing of Public Offering of Securities
GlobeNewswire
·
June 11, 2025
PHILADELPHIA, June 11, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (“Cabaletta” or the “Company”) (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically …
PESG Research Update: PolyPid SHIELD’s II Delivers Transformative Phase 3 Topline Results - Paradigm Shift in Surgical Infection Prevention
GlobeNewswire
·
June 11, 2025
On June 9th, PolyPid Ltd.* announced landmark topline results from its pivotal SHIELD II Phase 3 trial, demonstrating that D-PLEX100 achieved statistically significant reductions across all primary and secondary endpoints in preventing surgical site …
Wandercraft announces Series D Round, bringing $75M in total funding secured for global acceleration of AI-powered robotics
GlobeNewswire
·
June 11, 2025
Clinical progress, industrial partnerships, and global recognition drive momentum in rehabilitation, personal mobility, and humanoid robotics. New agreement with Renault Group accelerates commercialization and advances Wandercraft’s global robotics …
Capricor Therapeutics Announces Key Regulatory Updates for its Duchenne Muscular Dystrophy Program
GlobeNewswire
·
June 11, 2025
U.S. FDA successfully completed Pre-License Inspection; Company expects facility will meet all requirements to support licensure Advisory Committee meeting scheduled for July 30, 2025 Mid-cycle meeting recently completed with no significant issues or major …
Moleculin Participates in Virtual Investor “What This Means” Segment
GlobeNewswire
·
June 11, 2025
Globally recognized Oncology Key Opinion Leader, Brian Andrew Van Tine, MD, PhD, discusses the positive topline results from the U.S. Phase 1B/2 clinical trial evaluating Annamycin for the treatment of Soft Tissue Sarcoma Lung Metastases (MB-107) Watch the …
Inspira’s ART100 in Use at Tier-1 U.S. Hospitals, Generating Strong Clinical Interest and Accelerating Sales Discussions
GlobeNewswire
·
June 11, 2025
RA'ANANA, Israel, June 11, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira," “Inspira Technologies,” or the "Company"), a pioneer in innovative life-support and diagnostic technologies, announced today that its FDA- …
Majority of Diagnostic Laboratory Leaders Bet Big on Digital Pathology and AI
GlobeNewswire
·
June 11, 2025
PHILADELPHIA, June 11, 2025 (GLOBE NEWSWIRE) -- Diagnostic laboratory leaders view digital pathology and artificial intelligence (AI) as pivotal to advancing precision medicine. This perspective comes as organizations across the sector prioritize …
Project 55 Launches Free Mental Health First Responder Training for Public Use
GlobeNewswire
·
June 11, 2025
Project 55 Logo LADERA RANCH, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Project 55, a nonprofit organization focused on improving mental health outcomes in the workplace, is launching its Mental Health First Responder Training—a no-cost, online program …
Femasys Announces Partnership with Carolinas Fertility Institute, One of America’s Best Fertility Clinics, to Offer FemaSeed® in its More than 8 Locations
GlobeNewswire
·
June 11, 2025
-- Femasys continues to expand access and market share for its first-line infertility treatment option, FemaSeed® -- ATLANTA, June 11, 2025 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical innovator addressing significant unmet needs …
Fate Therapeutics Announces Updated Clinical Data for FT819 Off-the-shelf CAR T-cell Product Candidate Demonstrating Durability of Drug-free Remission for Severe Lupus Nephritis at EULAR 2025 Congress
GlobeNewswire
·
June 11, 2025
All three patients treated with FT819 following fludarabine-free conditioning regimen for severe lupus nephritis achieve Primary Efficacy Renal Response (PERR); first patient to reach 1-year follow-up continues in drug-free Definition of Remission in SLE ( …
Precision Neuroscience Expands Leadership Team With Key Hires From Meta and FDA
GlobeNewswire
·
June 11, 2025
NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision), a leading brain–computer interface (BCI) company, today announced the addition of two senior leadership hires. Vanessa Tolosa, PhD, a Neuralink co-founder and …
The Joint Commission and Coalition for Health AI Join Forces to Scale the Responsible Use of AI in Delivering Better Healthcare
GlobeNewswire
·
June 11, 2025
OAKBROOK TERRACE, Illinois, June 11, 2025 (GLOBE NEWSWIRE) -- The Joint Commission, an independent, evidence-based healthcare standard setting organization, and the Coalition for Health AI (CHAI), a nonprofit organization founded by clinicians to advance …
Management Confidence: Shineco Executives Launch up to $2M Open-Market Stock Purchase Program
GlobeNewswire
·
June 11, 2025
BEIJING, June 11, 2025 (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, today announced that Ms. Jennifer Zhan, the Company’s chief executive …
Windtree Receives Offer for Its Preclinical Oncology Drug Candidate
GlobeNewswire
·
June 11, 2025
Company to receive $7.0 million up front for its preclinical oncology drug candidate Up to $130.0 million in milestone payments starting with initiation of Phase 1 High single digit royalties that could total up to $1.5 billion over the life of the drug …
Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears
GlobeNewswire
·
June 11, 2025
SARASOTA, FL, June 11, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced that the U.S. Patent and …
Veru to Participate in the Virtual BTIG Obesity Health Forum
GlobeNewswire
·
June 11, 2025
MIAMI, FL, June 11, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced the company …
Lisata Therapeutics to Present at the 2025 BIO International Convention
GlobeNewswire
·
June 11, 2025
BASKING RIDGE, N.J., June 11, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other …
Genomics Market to Hit US$66.8 Billion by 2029 with 9.4% CAGR | MarketsandMarkets™.
GlobeNewswire
·
June 11, 2025
Delray Beach, FL, June 11, 2025 (GLOBE NEWSWIRE) -- The global genomics market, valued at US$42.4 billion in 2023, stood at US$42.6 billion in 2024 and is projected to advance at a resilient CAGR of 9.4% from 2024 to 2029, culminating in a forecasted …